Skip to content

OVID - Ovid Therapeutics Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchO

Ovid Therapeutics Inc

OVID · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

O

OVIDOvid Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $3.11
52-wk low: $0.94
Prev close: $1.97
Mkt cap: $530.1M
Fwd P/E: 1.8x
Beta: 0.23

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$80.0M

BA
Balyasny
Dmitry Balyasny · Q2 2026 13F
$18.1M
position
P7
Point72
Steven Cohen · Q2 2026 13F

Earnings

Reported Aug 12, 2026

Earnings came in 20.0% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 1.79
Market cap: $530M

Valuation

P/S334.84
P/B2.70

Quality

Operating margin-2101.0%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: OVID
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $530.06M
Beta: 0.23

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

334.8x

P/B

2.7x

Profit margin

+0.0%

Op margin

-2101.0%

ROE

-26.0%

$5.2M

position

TS

Two Sigma

Q2 2026 13F

$2.2M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for OVID

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.08+20.0%

-$0.10 expected

Next report

What the street expects next

EPS expected

-$0.09

-$0.10 to -$0.08

Revenue expected

$14.2K

10 analysts

Last 30 days

1up3down

Analysts cutting estimates

Estimate drift

+0.02

Change in 30 days

ROE

-26.0%

ROA-23.5%

Growth

Beta0.23